RT Journal Article
SR Electronic
T1 Physician Perceptions of Catching COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.15.20249089
DO 10.1101/2021.01.15.20249089
A1 Doraiswamy, P. Murali
A1 Chilukuri, Mohan
A1 Ariely, Dan
A1 Linares, Alexandra R.
YR 2021
UL http://medrxiv.org/content/early/2021/01/24/2021.01.15.20249089.abstract
AB Background Risk perception, influenced and biased by multiple factors, can affect behavior.Objective To assess the variability of physician perceptions of catching COVID-19.Design Cross sectional, random stratified sample of physicians registered with Sermo, a global networking platform open to verified and licensed physicians.Main outcome measures The survey asked: “What is your likelihood of catching COVID-19 in the next three months?” The physicians were asked to give their best estimate as an exact percentage.Results The survey was completed by 1004 physicians (40 countries, 67 specialties, 49% frontline [e.g. ER, infectious disease, internal medicine]) with a mean (SD) age of 49.14 (12) years. Mean (SD) self-risk estimate was 32.3% ± 26% with a range from 0% to 100% (Figure 1a). Risk estimates were higher in younger (<50 years) doctors and in non-US doctors versus their older and US counterparts (p<0.05 for all) (Figure 1b). Risk estimates were higher among front line versus non-frontline doctors (p<0.05). Risk estimates were higher for women than men (p<0.05) among respondents (60%) reporting gender.Conclusions To our knowledge, this is the first global study to document physician risk perceptions for catching COVID-19 and how it is impacted by age, gender, practice specialty and geography. Accurate calibration of risk perception is vital since both over- and underestimation of risk could impact physician behavior and have implications for public health.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no external funding support for these analyses and have no financial ties to Sermo. Sermo provided the platform but was not involved in data interpretation, manuscript preparation, or decision to submit. Authors had full access to all the data and accept responsibility to submit for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This anonymous survey was conducted in September 2020 following an online informed consent process. This was a broad survey across many topics of which one question pertained to immunology. De-identified data was analyzed for this report. This was reviewed and deemed exempt research by the Duke University Medical Center Institutional Review Board.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available upon request.